NM_174936.4:c.1503+50_1503+71delGTGTGTGTGTGTGTGTGTGTGT
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP6_Very_Strong
The NM_174936.4(PCSK9):c.1503+50_1503+71delGTGTGTGTGTGTGTGTGTGTGT variant causes a intron change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00060 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00085 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
PCSK9
NM_174936.4 intron
NM_174936.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.564
Publications
1 publications found
Genes affected
PCSK9 (HGNC:20001): (proprotein convertase subtilisin/kexin type 9) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an autocatalytic processing event with its prosegment in the ER and is constitutively secreted as an inactive protease into the extracellular matrix and trans-Golgi network. It is expressed in liver, intestine and kidney tissues and escorts specific receptors for lysosomal degradation. It plays a role in cholesterol and fatty acid metabolism. Mutations in this gene have been associated with autosomal dominant familial hypercholesterolemia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
PCSK9 Gene-Disease associations (from GenCC):
- hypercholesterolemia, autosomal dominant, 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- homozygous familial hypercholesterolemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP6
Variant 1-55058666-CGTGTGTGTGTGTGTGTGTGTGT-C is Benign according to our data. Variant chr1-55058666-CGTGTGTGTGTGTGTGTGTGTGT-C is described in ClinVar as Likely_benign. ClinVar VariationId is 492233.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000597 AC: 85AN: 142440Hom.: 0 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
85
AN:
142440
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000850 AC: 1184AN: 1392822Hom.: 0 AF XY: 0.000798 AC XY: 551AN XY: 690614 show subpopulations
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1184
AN:
1392822
Hom.:
AF XY:
AC XY:
551
AN XY:
690614
show subpopulations
African (AFR)
AF:
AC:
12
AN:
31608
American (AMR)
AF:
AC:
3
AN:
39552
Ashkenazi Jewish (ASJ)
AF:
AC:
3
AN:
24878
East Asian (EAS)
AF:
AC:
0
AN:
36984
South Asian (SAS)
AF:
AC:
6
AN:
81354
European-Finnish (FIN)
AF:
AC:
12
AN:
47984
Middle Eastern (MID)
AF:
AC:
1
AN:
4014
European-Non Finnish (NFE)
AF:
AC:
1114
AN:
1068890
Other (OTH)
AF:
AC:
33
AN:
57558
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
50
100
149
199
249
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000597 AC: 85AN: 142440Hom.: 0 Cov.: 0 AF XY: 0.000566 AC XY: 39AN XY: 68950 show subpopulations
GnomAD4 genome
AF:
AC:
85
AN:
142440
Hom.:
Cov.:
0
AF XY:
AC XY:
39
AN XY:
68950
show subpopulations
African (AFR)
AF:
AC:
6
AN:
37766
American (AMR)
AF:
AC:
2
AN:
14588
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3364
East Asian (EAS)
AF:
AC:
0
AN:
4752
South Asian (SAS)
AF:
AC:
0
AN:
4378
European-Finnish (FIN)
AF:
AC:
3
AN:
9152
Middle Eastern (MID)
AF:
AC:
0
AN:
296
European-Non Finnish (NFE)
AF:
AC:
74
AN:
65320
Other (OTH)
AF:
AC:
0
AN:
1944
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.542
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hypercholesterolemia, autosomal dominant, 3 Benign:1
Dec 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Hypercholesterolemia, familial, 1 Benign:1
Sep 05, 2017
Color Diagnostics, LLC DBA Color Health
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.